The Drug Dilemma PDF Download

Author: Sidney Cohen
Publisher: McGraw-Hill Companies
ISBN:
Category : Drug abuse
Languages : en
Pages : 128

View

Book Description

Author: Jason Stone
Publisher: IDEA
ISBN: 9780972054126
Category : Political Science
Languages : en
Pages : 278

View

Book Description
The anthology is designed as a starting point for academic debate about illegal drugs. The 25 reprinted articles cover reducing harm and reduction, law enforcement, supply reduction, the European Union's drug policies, and terrorism and drugs. Each appends suggested topics for debate. They are not i

Author:
Publisher:
ISBN:
Category : Brain
Languages : en
Pages : 76

View

Book Description

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483

View

Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Author: Bruce White
Publisher: CRC Press
ISBN: 1000572552
Category : Business & Economics
Languages : en
Pages : 352

View

Book Description
Weigh pivotal healthcare ethics, law, and public policy issues that resulted in tipping-point legal actions Weighing the ethical considerations in healthcare and drug issues can be emotionally difficult and mentally challenging. Drugs, Ethics, and Quality of Life: Cases and Materials on Ethical, Legal, and Public Policy Dilemmas in Medicine and Pharmacy Practice is a fascinating casebook that clearly discusses the most contentious ethical conflicts that resulted in legal actions. This easy-to-read text provides all sides of controversial real-life cases that provoke spirited debate while teaching the fundamentals of pharmacy law and ethics. The book is a unique exploration into the basic principles of bioethics, end of life care, and drug research. Drugs, Ethics, and Quality of Life explains in detail the concepts of ethics, quality of life, beneficence, nonmaleficence, autonomy, and justice. Recent cases provide illuminating backdrops for the exploration of these concepts, making them easily understood. A special introduction includes important information about ethics and the pharmaceutical code of ethics. Two appendixes provide further opportunities for discussion and the examination of law and decisions, and resources about drug use decisions and situations. This thought-provoking textbook plainly shows the crucial role ethics plays in today’s society. Ethical topics explored in Drugs, Ethics, and Quality of Life includes legal cases on: tobacco COX-2 inhibitors medical marijuana the “morning after” pill and other emergency contraceptives pain medications and palliative care drugs physician-assisted suicide drug use in medically futile situations gene therapy Drugs, Ethics, and Quality of Life is valuable, insightful reading as well as a good adjunct text for pharmacy students, pharmacists, medical students, physicians, bio

Author: Sidney Cohen
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 168

View

Book Description

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377

View

Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Author: Andrea M. Leverentz
Publisher: Rutgers University Press
ISBN: 0813562295
Category : Social Science
Languages : en
Pages : 249

View

Book Description
When a woman leaves prison, she enters a world of competing messages and conflicting advice. Staff from prison, friends, family members, workers at halfway houses and treatment programs all have something to say about who she is, who she should be, and what she should do. The Ex-Prisoner’s Dilemma offers an in-depth, firsthand look at how the former prisoner manages messages about returning to the community. Over the course of a year, Andrea Leverentz conducted repeated interviews with forty-nine women as they adjusted to life outside of prison and worked to construct new ideas of themselves as former prisoners and as mothers, daughters, sisters, romantic partners, friends, students, and workers. Listening to these women, along with their family members, friends, and co-workers, Leverentz pieces together the narratives they have created to explain their past records and guide their future behavior. She traces where these narratives came from and how they were shaped by factors such as gender, race, maternal status, age, and experiences in prison, halfway houses, and twelve-step programs—factors that in turn shaped the women’s expectations for themselves, and others’ expectations of them. The women’s stories form a powerful picture of the complex, complicated human experience behind dry statistics and policy statements regarding prisoner reentry into society for women, how the experience is different for men and the influence society plays. With its unique view of how society’s mixed messages play out in ex-prisoners’ lived realities, The Ex-Prisoner’s Dilemma shows the complexity of these women’s experiences within the broad context of the war on drugs and mass incarceration in America. It offers invaluable lessons for helping such women successfully rejoin society.

Author: Howard Rahtz
Publisher: Hamilton Books
ISBN: 0761859683
Category : Social Science
Languages : en
Pages : 153

View

Book Description
Forty years ago, President Richard Nixon declared a “war on drugs.” Since that time, the country has incarcerated thousands of citizens and spent billions of dollars, and yet the drug problem rolls on. Today, the illegal drug market funds international terrorism, the horrific drug war on the Mexican border, and the senseless violence plaguing our communities, large and small. It is past time for a new direction. This book provides a drug policy framework that will choke off the revenue supporting the illegal drug market. Howard Rahtz outlines a series of drug policy steps buttressed by a historical review of drug policy measures, a review of international efforts against trafficking, and a clear understanding of the dynamics of addiction and its role in facilitating the illegal drug market.

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309225493
Category : Medical
Languages : en
Pages : 432

View

Book Description
The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.